US Stock MarketDetailed Quotes
AGE AgeX Therapeutics
- 11.1000
- 0.00000.00%
Close Mar 26 16:00 ET
27.76MMarket Cap-809P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open11.1000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)2.50MShares35.170052wk High5.08P/B27.16MFloat Cap10.902752wk Low--Dividend TTM2.45MShs Float209.2615Historical High--Div YieldTTM0.00%Amplitude10.9027Historical Low--Avg Price1Lot Size
About AgeX Therapeutics Company
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. The company's product pipeline includes two cell-based and two iTR-based product candidates in development. Its lead cell-based therapeutic candidates in development are AGEX-BAT1 and AGEX-VASC1. Its lead small molecule drug-based therapeutic candidate for iTRTM in discovery is AGEX-iTR1547.
Company Profile
SymbolAGE
Company NameAgeX Therapeutics
CEODr. Joanne M. Hackett, PhD
MarketAMEX
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.agexinc.com
Company Executives
- Name
- Position
- Salary
- Dr. Joanne M. Hackett, PhD
- Chairman of the Board and Interim Chief Executive Officer
- 103.07K
- Andrea E. Park
- Chief Financial Officer and Principal Accounting Officer
- 295.29K
- Dr. Hal Sternberg, PhD
- Vice President of Research
- 184.07K
- Steven M. Mintz
- Director
- --
- Dr. Jean-Christophe Renondin, M.D.
- Director
- --
- Dr. Gregory Hugh Bailey, M.D.
- Independent Director
- 49.01K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg